Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy
用户48_KcjR1ENS0
2个月前
66
10
已完结
1. 系统已在2025-05-19 15:49:41对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.neuropharm.2024.110048
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S002839082400217X
其他信息:
出版社: Elsevier BV
作者: Nazzareno Cannella; Veronica Lunerti; Qianwei Shen; Hongwu Li; Federica Benvenuti; Laura Soverchia; Rajesh Narendran; Friedbert Weiss; Roberto Ciccocioppo
